10X Genomics Reports Q2 Preliminary Revenues, Shares Plummet On Missing Street Expectation
10X Genomics Inc (NASDAQ:TXG) reported preliminary second-quarter revenue is expected to be ~$114.5 million, a decrease of 1% year-over-year, below the…